16 reports of this reaction
1.6% of all SILVER NITRATE reports
#17 most reported adverse reaction
COGNITIVE DISORDER is the #17 most commonly reported adverse reaction for SILVER NITRATE, manufactured by Boiron. There are 16 FDA adverse event reports linking SILVER NITRATE to COGNITIVE DISORDER. This represents approximately 1.6% of all 1,031 adverse event reports for this drug.
Patients taking SILVER NITRATE who experience cognitive disorder should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
COGNITIVE DISORDER is a less commonly reported adverse event for SILVER NITRATE, but still significant enough to appear in the safety profile.
In addition to cognitive disorder, the following adverse reactions have been reported for SILVER NITRATE:
The following drugs have also been linked to cognitive disorder in FDA adverse event reports:
COGNITIVE DISORDER has been reported as an adverse event in 16 FDA reports for SILVER NITRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
COGNITIVE DISORDER accounts for approximately 1.6% of all adverse event reports for SILVER NITRATE, making it a notable side effect.
If you experience cognitive disorder while taking SILVER NITRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.